Skip to main content

School of Medicine

VUMC chikungunya antibody set to enter clinical trial

Feb. 21, 2019—A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial.

Read more


Discovery of new “checkpoint” points to new cancer immunotherapy option

Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.

Read more


Research shows frogs can adapt to traffic noise

Feb. 21, 2019—Frogs don’t like living near noisy highways any better than people do, but research from Vanderbilt suggests that frogs, like hardened city-dwellers, can learn to adapt to the constant din of rumbling trucks, rolling tires and honking horns.

Read more


Study takes personal approach to cochlear implant programming

Feb. 21, 2019—Vanderbilt University Medical Center recently received a $3.9 million grant from the National Institutes of Health to improve outcomes for children with significant hearing loss by providing individualized, prescription-like programming for their cochlear implants.

Read more


Adhesion protein optimizes border

Feb. 15, 2019—Matthew Tyska and colleagues have found that an adhesion protein in the gut is necessary for proper intestinal functioning.

Read more


The balancing act of cell signaling

Feb. 15, 2019—Lawrence Marnett and colleagues have demonstrated how two enzymes cooperate to maintain even levels of an important cellular signaling molecule.

Read more


Probing H. pylori cancer protein

Feb. 15, 2019—Timothy Cover, john Loh and colleagues have identified how a certain type of mutation influences the risk of premalignant and malignant changes in the stomach.

Read more


Researchers push forward frontiers of vaccine science

Feb. 13, 2019—Using sophisticated gene sequencing and computing techniques, Vanderbilt researchers have achieved a first-of-its-kind glimpse into how the body’s immune system gears up to fight off infection.

Read more


Flexner Deans’ Lecture: Dr. Mamta Swaroop Feb. 25

Feb. 8, 2019—Mamta Swaroop, associate professor of surgery at Feinberg School of Medicine, will discuss "TRUE COMMUNITIES: An Evolution of Empowerment" as part of the Flexner Deans' Lecture Series.

Read more


Symposium shines light on research by medical students

Feb. 8, 2019—The symposium featured research by students in Vanderbilt's Medical Scholars Program, a one-year, in-depth research experience available to Vanderbilt and Meharry Medical College students with the central goal of training leaders in academic medicine.

Read more


New option could increase minority kidney transplants

Feb. 7, 2019—People with blood type B, a relatively rare blood type, can expect similar outcomes from kidney transplants from type A2 donors, which increases the number of available kidneys for these patients. However, it requires additional monitoring and medication that can raise costs for patients.

Read more


New target for chronic kidney disease

Jan. 31, 2019—Craig Brooks and colleagues have identified a mechanism of kidney fibrosis progression, suggesting a potential new angle for treating chronic kidney disease.

Read more


VIEW MORE EVENTS >